Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Neuroimmunology & Neuroinflammation
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

Share

May 2018; 5 (3) Editor's CornerOpen Access

Looks can be deceiving

A B-cell–mediated encephalopathy with normal MRI?

Josep Dalmau
First published April 12, 2018, DOI: https://doi.org/10.1212/NXI.0000000000000461
Josep Dalmau
MD, PhDNeurology®: Neuroimmunology & Neuroinflammation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Looks can be deceiving
A B-cell–mediated encephalopathy with normal MRI?
Josep Dalmau
Neurol Neuroimmunol Neuroinflamm May 2018, 5 (3) e461; DOI: 10.1212/NXI.0000000000000461

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
613

Share

  • Article
  • Info & Disclosures
Loading

Embedded Image

Advances in defining clinical criteria and immunologic biomarkers of autoimmune diseases such as MS or autoimmune encephalitides coupled with conventional MRI studies and diffusion tensor imaging (DTI) have revealed overlapping diseases characterized by autoantibodies against neuronal or glial surface proteins (NMDA receptor, aquaporin 4, or myelin oligodendrocyte glycoprotein)1,2 and may disclose in the future unclassified autoimmune disorders with yet unknown mechanisms. For those readers who are impatient, the future is now. In this issue of Neurology® Neuroimmunology & Neuroinflammation, Dr. Takewaki et al.3 describe 11 patients whose symptoms and clinical course mimicked MS, but without abnormalities on conventional MRI studies. None of the patients had oligoclonal bands in the CSF, and most had extensive white matter abnormalities identified by MRI DTI characterized by a decrease in fractional anisotropy values. Treatment with IV methylprednisolone and plasma exchange were often effective. These findings and the presence of frequent plasmablasts in the peripheral blood suggested that the underlying pathogenesis was likely mediated by B-cell mechanisms. The authors named this disorder “normal-appearing imaging-associated, neuroimmunologically justified, autoimmune encephalomyelitis.” In the accompanying editorial comment, Dr. Finke4 discusses the type of disease that these patients may have and indicates similar clinical-radiologic dissociations noted in other diseases. An example is anti-NMDA receptor encephalitis, where patients with severe symptoms often have normal conventional MRI studies, but DTI reveals extensive white matter abnormalities with decreased fractional anisotropy.5 Further studies are needed to characterize this category of MRI-negative autoimmune encephalitis, which perhaps in the future may be defined by yet unknown immunologic biomarkers.

In another study, Dr Rissanen et al.6 used PET to investigate the relationship of in vivo microglial activation to clinical and MRI parameters in MS. Microglia activation is associated with increased levels of the 18-kDa translocator protein, which the authors measured with the PET tracer [11C](R)-PK11195. Patients with secondary progressive and relapsing-remitting MS (RRMS) and age-matched healthy participants were included in the study. The authors found differences in the amount and distribution of the PET tracer in patients with secondary progressive as compared to RRMS and healthy participants. Higher binding of the tracer in normal-appearing white matter also associated with higher clinical disability and reduced white matter structural integrity. Among patients with MS, older age associated with higher microglial activation in normal-appearing white matter. The study suggests that increased microglial activity in the normal-appearing white matter correlates closely with impaired white matter structural integrity, providing a potential pathologic correlate to DTI parameters.

In another article, Dr. Radke et al. describe the composition, organization, and presence of different B-cell subpopulations in patients with dermatomyositis (DM) and the relationship of these B-cell infiltrates to specific cytokines and chemokines involved in lymphoid neogenesis.7 Twenty-three patients were enrolled, including cases with anti-Mi2 autoantibodies and excluding those with antisynthetase antibodies or necrotizing myopathy and signal recognition particle antibodies. Based on the inflammatory infiltrates and B-cell distribution, 3 groups of adults with DM (aDM) were identified: (1) classic aDM, with inflammatory infiltrates diffusely distributed and mainly located in the perimysium and partly in the adjacent endomysium, and rare CD20+ B lymphocytes; (2) B-cell–rich aDM, with more inflammatory infiltrates and dense CD20+ B-cell aggregates; and (3) follicle-like aDM, showing follicle-like structures, resembling tertiary lymphoid organs with germinal centers and dark and light zone organization. A significant upregulation of numerous genes implicated in different aspects of the interferon signature was found in the B-cell–rich and follicle-like aDM. The authors suggest that assessment of B-cell architecture, including ultrastructure and function, together with interferon signature genes can be useful tools to stratify patients with DM and develop therapies targeting these disease subsets individually (e.g., B-cell immunity or type 1 interferon signaling).

In another article, Dr. Cohen Aubart et al.8 report a nationwide retrospective study of the clinical-pathologic presentations of muscular sarcoidosis. Forty-eight patients (28 women), median age at muscle symptom onset of 45 years (range 18–75 years), were enrolled. Forty patients had definite neurosarcoidosis confirmed by muscle biopsy, and 8 had probable neurosarcoidosis. Four clinical-pathologic patterns were identified, “myopathic,” defined by the presence of motor deficits; “nodular,” characterized by the presence of nodular lesions without motor deficit; “smoldering,” defined by the presence of constant myalgias and absence of nodular lesions, motor deficits and amyotrophy; and “combined myopathic and neurogenic,” characterized by the presence of a neurogenic pattern in electrophysiologic studies, in addition to muscle involvement. These 4 patterns differed according to symptom presentation (myalgia, nodules, and weakness), electrophysiologic and MRI findings, and response to treatment. After a median follow-up period of 6 years, patients with myopathic and neuromuscular patterns had the worse outcome.

In addition to these studies, the May issue of Neurology: Neuroimmunology & Neuroinflammation contains other interesting articles that I hope will catch your attention.

Study funding

No targeted funding reported.

Disclosure

J. Dalmau is the editor of Neurology: Neuroimmunology & Neuroinflammation; is on the editorial board of Neurology UpToDate; holds patents for and receives royalties from Ma2 autoantibody test, NMDA receptor autoantibody test, GABA(B) receptor autoantibody test, GABA(A) receptor autoantibody test, DPPX autoantibody test, and IgLON5 autoantibody test; and receives research support from NIH, Fundació CELLEX, and Instituto Carlos III (CIBERER and Fondo de Investigaciones Sanitarias). Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NN.

Footnotes

  • Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NN.

  • Editor Summary: NPub.org/N2/edsum

  • Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

References

  1. 1.↵
    1. Titulaer MJ,
    2. Hoftberger R,
    3. Iizuka T, et al
    . Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014;75:411–428.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Hacohen Y,
    2. Absoud M,
    3. Hemingway C, et al
    . NMDA receptor antibodies associated with distinct white matter syndromes. Neurol Neuroimmunol Neuroinflamm 2014;1:e2. doi: 10.1212/NXI.0000000000000002.
    OpenUrlCrossRef
  3. 3.↵
    1. Takewaki D,
    2. Lin Y,
    3. Sato W, et al
    . Normal brain imaging accompanies neuroimmunologically justified, autoimmune encephalomyelitis. Neurol Neuroimmunol Neuroinflamm 2018;5:e456. doi: 10.1212/NXI.0000000000000456.
    OpenUrl
  4. 4.↵
    1. Finke C
    . Diagnosing MRI-negative autoimmune diseases. Neurol Neuroimmunol Neuroinflamm 2018;5:e457. doi: 10.1212/NXI.0000000000000457.
    OpenUrl
  5. 5.↵
    1. Peer M,
    2. Pruss H,
    3. Ben-Dayan I,
    4. Paul F,
    5. Arzy S,
    6. Finke C
    . Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study. Lancet Psychiatry 2017;4:768–774.
    OpenUrl
  6. 6.↵
    1. Rissanen E,
    2. Tuisku J,
    3. Vahlberg T, et al
    . Microglial activation, white matter tract damage and disability in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 2018;5:e443. doi: 10.1212/NXI.0000000000000443.
    OpenUrl
  7. 7.↵
    1. Radke J,
    2. Koll R,
    3. Preusse C, et al
    . Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis. Neurol Neuroimmunol Neuroinflamm 2018;5:e451. doi: 10.1212/NXI.0000000000000451.
    OpenUrl
  8. 8.↵
    1. Cohen Aubart F,
    2. Abbara S,
    3. Maisonobe T, et al
    . Symptomatic muscular sarcoidosis: lessons from a nation-wide multicenter study. Neurol Neuroimmunol Neuroinflamm 2018;5:e452. doi: 10.1212/NXI.0000000000000452.
    OpenUrl

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Study funding
    • Disclosure
    • Footnotes
    • References
  • Info & Disclosures
Advertisement

Association Between Fluctuations in Blood Lipid Levels Over Time With Incident Alzheimer Disease and Alzheimer Disease–Related Dementias

Dr. Sevil Yaşar and Dr. Behnam Sabayan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Article
    Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging
    Svetlana Bezukladova, Jouni Tuisku, Markus Matilainen et al.
    Neurology: Neuroimmunology & Neuroinflammation, March 02, 2020
  • Article
    Microglial activation, white matter tract damage, and disability in MS
    Eero Rissanen, Jouni Tuisku, Tero Vahlberg et al.
    Neurology: Neuroimmunology & Neuroinflammation, March 06, 2018
  • Articles
    Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor
    G. Nicoletti, D. Manners, F. Novellino et al.
    Neurology, March 22, 2010
  • Article
    White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease
    Ian O. Bledsoe, Glenn T. Stebbins, Doug Merkitch et al.
    Neurology, November 14, 2018
Neurology - Neuroimmunology Neuroinflammation: 10 (6)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Neuroimmunology & Neuroinflammation
Online ISSN: 2332-7812

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise